Personalized Medicine

Personalized medicine draws upon the fact that every patient is a unique individual. This individuality is written into our genes, and can influence the efficacy of medications, influence the development of serious drug side-effects, and increase the risk for drug-to-drug interactions.  Pharmacogenetic tests powered by AssureRx’s GeneSightRx® technologymay help physicians prescribe appropriate therapies for their patients by accounting for their individual genetic differences.

GeneSightRx®

GeneSightRx is a clinically focused technology developed by AssureRx Health that measures and analyzes important genomic variants affecting the metabolism and response to behavioral health medications in individual patients. These laboratory-developed genomic tests serve as a clinical treatment support tool for your practice, providing you with objective genetic-based patient information in advance of making a medication decision for your patient. Knowing a patient’s genetic profile and having it available in a clear and easy to interpret report can help you understand which medications the patient would metabolize properly and help inform treatment choices unique to each patient.

AssureRx Health products powered by GeneSightRx technology include:

GeneSightRx Psychotropic

Pharmacogenomic test developed by AssureRx Health to help clinicians select medications commonly prescribed to treat neuropsychiatric disorders such as depression, bipolar disorder and schizophrenia based on the genetic factors affecting how individual patients metabolize and respond to certain medications.

GeneSightRx ADHD

Pharmacogenomic test developed by AssureRx Health that helps clinicians determine how genetic variants affect individual patient’s ability to metabolize and respond to medications for Attention Deficit/Hyperactivity Disorder (ADHD). Clinicians may use this information, combined with their medical expertise, to support selection of an appropriate treatment plan for each patient.

GeneSightRx Analgesic

Pharmacogenomic test developed by AssureRx Health to assess a patient’s unique genetic makeup to better understand how genetic variants influence the way they metabolize and respond to medications commonly prescribed to treat chronic pain.

About AssureRx Health, Inc.

AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenetics and is dedicated to helping physicians determine the right drug and manage side-effects for individual patients suffering from various medical conditions. Learn more athttp://www.assurerxhealth.com

Useful links:

About AssureRx Health: http://www.assurerxhealth.com/about

About GeneSightRx: http://www.assurerxhealth.com/GeneSightRx

Patient Education Materials: http://www.assurerxhealth.com/patient_information

YouTube Channel: http://www.youtube.com/user/assurerxmarketing?blend=7&ob=5

Facebook Page: https://www.facebook.com/assurerxhealth

Twitter Page: http://twitter.com/#!/assurerx_health

We’ve moved!

Our Skillman office is now located at 11 Tamarack Circle.

Depression is the second-most common cause of disability in the country. Adult lifetime prevalence of major depressive disorder (MDD) is 13–16% in the United States.  MDD symptoms can be multifctorials and can be associated with deficits in three main domains. The mood symptoms, which include depressed mood and loss of interest or pleasure. The physical symptoms, lack of energy, changes in appetite and disturbances in the sleep. The third dmoin includes cognitive deficits, such as lack of attention, poor concentration and impaired memory. The longer a patient has been depressed, the likelihood of spontaneous recovery of depression decreases. Approximately one-third of major depressive episodes do not resolve, and about 15% of patients with severe MDD successfully commit suicide.

Currently, there is an important unmet need for additional antidepressant options. “Many patients fail to respond to many medication treatments and even if partial response is achieved, there often tolerability issues with the medication. For patients which current medications are not enough to improve the depression, we are offering alternative therapies such as TMS and Intranasal Ketamine. NeuroStar TMS Therapy is an FDA-cleared safe and effective non-drug depression treatment for patients who are not satisfied with the results of standard drug therapy. This novel treatment option provides benefits without the side effects often associated with antidepressant medication.

Ketamine, an FDA-approved anesthetic which is an NMDA receptor antagonist, has been used in animals and humans for many decades. Ketamine has already shown promisein providing rapid relief of depression, with tolerable side effects. In specific, Intranasal Ketamine is another available treatment for severe depression. Published data, suggest that intranasal ketamine is safe and effective for rapid reduction of depressive symptoms in patients with treatment-resistant depression.Often, improvement in symptoms can be observed within the first few treatments. The intranasal route for drug delivery has been of interest to investigators because it is non-invasive, and may offer rapid absorption and delivery. In addition, the ease of administration may potentially improve compliance. The response to Ketamine is individualized, some can used every other day, or every week. Contact your Team at Aroga Medical Associates for further details.

Obesity is a growing problem in the United States. Negative health outcomes associated with obesity include worsening symptoms of depression and anxiety, cerebrovascular and heart disease, high blood pressure, diabetes and more.  At Aroga, clinical interventions, such as medications and psychotherapy, will elicit and enhance your motivation to maintain both healthy diet and regular exercise. We will help you to achieve optimal weight and improve your overall health.